
Sign up to save your podcasts
Or


Dr. Bob Harrington, an interventional cardiologist and Chairman of the Department of Medicine at Stanford University, speaks with Venrock's Dr. Bob Kocher about his passion for coagulation and thrombosis (seriously, he loves it) and his involvement with Gusto, a clinical trial that changed the way doctors treat heart attack patients. Bob also talks about working with an executive coach to develop new skills, when he found himself managing teams at Duke Clinical Research Institute.
By Venrock, a venture capital firm4.8
6262 ratings
Dr. Bob Harrington, an interventional cardiologist and Chairman of the Department of Medicine at Stanford University, speaks with Venrock's Dr. Bob Kocher about his passion for coagulation and thrombosis (seriously, he loves it) and his involvement with Gusto, a clinical trial that changed the way doctors treat heart attack patients. Bob also talks about working with an executive coach to develop new skills, when he found himself managing teams at Duke Clinical Research Institute.

1,289 Listeners

2,672 Listeners

2,444 Listeners

1,100 Listeners

341 Listeners

324 Listeners

394 Listeners

5,526 Listeners

9,901 Listeners

34 Listeners

505 Listeners

19 Listeners

263 Listeners

517 Listeners

1,354 Listeners